Outsourcing channel feed – Endpoints News

SIGN UP

Outsourcing channel feed

CRO Fortrea 'disputes the accuracy' of Acelyrin's claims about immunology drug trial conduct

Last week

Danaher’s third-quarter revenue from biotech services down 19% amid slowdown in China, US

Last month

Thermo Fisher reels in proteomics company Olink in $3.1B deal

Last month

Looking for an edge in a competitive market, Oxford Nanopore moves into mRNA vaccine testing

2 months ago

Updated: As sales continue to slide, Catalent reaches deal with activist to add board seats and conduct review

3 months ago

CRO Syneos Health didn't hold up its end of the deal in enrollment for FSD Pharma's trial, arbitration panel finds

4 months ago

WuXi Biologics seeks spinout, HK listing of bioconjugates-focused joint venture

5 months ago

CVS will shut down clinical trials unit that it launched during Covid

6 months ago

CRO deal space continues to buzz as Genesis Drug Discovery buys JSS Medical Research

7 months ago

CRO Syneos Health to be acquired by a group of private equity firms for $7B+

7 months ago

On heels of Essex deal, CRO Emmes says it's planning to make more acquisitions this year

7 months ago

TandemAI raises $35M in Series A for small molecule discovery, wet labs

9 months ago

Pfizer was warned of Lyme study problems months ago, trial research startup's CEO tells employees

9 months ago

Flagship company teams up with Charles River for AI drug discovery

9 months ago

As clinical trials get more complex, software startup Faro bags $20M to help visualize them

10 months ago

Ready to expand, GenScript raises $224M for CDMO focused on antibodies, cell and gene therapies

10 months ago

Three Ohio-based contract organizations win $149M deal for neurological candidates

11 months ago

Novotech's latest acquisitions grow its US presence and plant a European foothold

11 months ago

CRO startup Vial scores $67M Series B led by General Catalyst

Last year

#CPHI22: Contract manufacturers will still be navigating global challenges into next year

Last year

After $10B in market value lost, China's WuXi Biologics removed from US unverified list

Last year

Forge Biologics continues its hot streak with $90M round to boost gene therapy manufacturing services

Last year

Australian CRO makes a move across the Pacific for US acquisition

Last year

CEO of Michigan CDMO explains how he nabbed monkeypox vaccine contract

Last year

12 3 4 Next page Last page